Gene Query: NUP54

Dataset Description Geneva Score
Dtx3L and Androgen Signaling in Prostate Cancer 30.17
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 27.73
Role for citron kinase in prostate cancer growth 27.1
HNRNPL and its RNA Targets in Prostate Cancer 24.78
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 24.78
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 19.06
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 18.87
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 17.99
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 17.99
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 17.57
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 16.46
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 15.42
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 14.4
RNAseq Study in CC-671 Treated Cal-51 Cells 13.93
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 11.35
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 11.07
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 11.07
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 10.96
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 10.83
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 10.57
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 10.52
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 10.52
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 10.4
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 10.3
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 10.17
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 10.08
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 10.08
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 9.94
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 9.92
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 9.92
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 9.77
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 9.71
Developmental stage specific chromosome architecture in human erythroid cells 9.71
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 9.68
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 9.38
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 9.38
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 9.3
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 9.02
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 8.95
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 8.9
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 8.88
Region-specific Innate Antiviral Responses of the Human Epididymis 8.86
RNAseq Analysis in glioblastoma cells treated with Mepazine 8.85
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 8.82
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 8.75
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 8.75
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 8.73
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 8.72
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 8.65
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 8.53
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 8.53
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 8.27
Co-transcriptional loading of RNA export factors shapes the human transcriptome 8.24
RNAseq of HEK293 cells after Chtop knockdown 8.24
Regulation of protein translation during mitosis 8.1
Expression profiling of etoposide-induced senescent cells 8.09
RNA-seq analysis of RALD iPSCs after in vitro differentiation 8.05
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 7.96
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 7.96
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 7.79
Differentially expressed vascular development genes for iPSC-ECs from CDI 7.76
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 7.74
RNAseq analysis of ESRP regulated splicing events in prostate cancer 7.69
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 7.66
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 7.6
The cohesin complex prevents Myc-induced replication stress 7.59
RNA-seq analysis of differentiating human erythroblasts 7.54
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 7.54
Targeting MTHFD2 in Acute Myeloid Leukemia 7.52
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 7.43
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 7.32
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 7.29
Transcriptomic analyssis following EHMT1/2 inhibition 7.28
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 7.26
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 7.25
Cerebellar differentiation in Ataxia-Telangiectasia 7.21
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 7.1
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 7.02
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 7.01
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 6.98
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 6.98
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 6.94
Total RNA-seq in ALL-SIL upon TLX1 knockdown 6.92
Examining serotonergic neuron differentiation from human iPSCs 6.85
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 6.79
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 6.77
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 6.76
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 6.76
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 6.76
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 6.76
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 6.74
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 6.72
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 6.72
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 6.7
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 6.7
Cajal bodies are linked to genome conformation 6.7
Cajal bodies are linked to genome conformation [RNA-Seq] 6.7
Lysine benzoylation is a novel histone mark 6.64
Lysine benzoylation is a novel histone mark [RNA-seq] 6.64
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 6.62
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 6.54
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 6.49
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 6.47
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 6.35
Integrating single-cell transcriptomic data across different conditions, technologies, and species 6.3
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 6.27
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 6.23
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 6.2
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 6.19
Reassessment of Exosome Composition 6.18
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 6.17
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 6.17
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 6.17
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 6.09
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 6.09
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 6.03
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 6.03
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 6.03
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 5.97
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 5.92
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 5.9
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 5.87
LNCaP treated with iBET 5.82
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 5.81
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 5.8
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 5.8
Effect of BB608 on Gene Expression in HNSCC Cell Line 5.8
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 5.79
Seletive inhibition of CDK9 in DLBCL cell lines 5.79
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 5.78
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 5.76
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 5.75
Ribosomal footprinting of CN34-Parental and CN34-LM1a 5.75
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 5.71
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 5.71
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 5.69
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 5.65
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 5.65
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 5.63
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 5.63
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 5.6
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 5.59
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 5.57
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 5.56
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 5.53
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 5.52
Global Mapping of Human RNA-RNA Interactions 5.49
Derivation and differentiation of haploid human embryonic stem cells 5.49
6mer seed toxicity in tumour suppressive microRNAs 5.48
RNA-seq analysis to identify the genes regulated by p53-SET interplay 5.43
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 5.42
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 5.41
R430: A potent inbibitor of DNA and RNA viruses 5.4
Integrin signaling regulates YAP/TAZ to control skin homeostasis 5.4
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 5.39
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 5.39
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 5.38
TGF-β regulation of miRNA expression in pancreatic cancer 5.31
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 5.3
Ribosomal footprinting of MDA-Parental and MDA-LM2 5.23
Hijacking of stress response machinery by oncogenes in acute leukaemia 5.23
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 5.23
Tracking distinct RNA populations using efficient and reversible covalent chemistry 5.22
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 5.15
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 5.15
LncRNA-GAS5 negative regulation of YAP-target genes expression 5.14
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 5.11
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 5.11
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 5.1
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 5.08
Human cell line and subcutaneous tumor 5.05
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 5.0
mRNA expression profile of Lymphocytes 4.95
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 4.94
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 4.94
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 4.93
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 4.92
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 4.91
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 4.91
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 4.9
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 4.87
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 4.87
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 4.83
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 4.83
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 4.79
Knockdown of ADNP in HCT116 colon cancer cells 4.78
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 4.75
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 4.75
Transcriptome analysis of H9 hESC derived cerebral organoids 4.74
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 4.73
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 4.7
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 4.7
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 4.68
ETV7 and interferon response 4.68
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 4.68
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 4.67
The effect of PPARG inhibition on human angiomyolipoma cells 4.66
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 4.65
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 4.65
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 4.63
Comprehensive comparative analysis of 5’ end RNA sequencing methods 4.62
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 4.57
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 4.57
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 4.57
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 4.56
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 4.55
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 4.55
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 4.55
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 4.55
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 4.54
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 4.54
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 4.53
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 4.51
GATA3-mediated chromatin reprogramming in breast cancer cells 4.51
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 4.46
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 4.42
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 4.39
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 4.33
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 4.33
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 4.32
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 4.23
FBXW7 modulates stress response by post-translational modification of HSF1 4.23
K562 polyA RNA-Seq 4.21
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 4.19
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 4.19
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 4.18
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 4.13
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 4.13
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 4.13
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 4.12
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 4.08
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 4.05
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 4.05
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 4.05
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 4.04
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 4.03
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 4.03
Tracing Enhancer Networks using Epigenetic Traits (TENET) 3.99
RNA expression analysis upon JMJD1C depletion 3.99
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 3.99
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 3.97
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 3.96
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 3.96
Dynamic reorganization of nuclear architecture during human cardiogenesis 3.96
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 3.95
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 3.95
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 3.83
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 3.79
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 3.78
AMPK signaling for naïve pluripotency [Hs] 3.78
AMPK signaling for naïve pluripotency 3.78
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 3.76
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 3.74
LIN28A Over-expression RNAseq 3.72
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 3.69
Molecular Criteria for Defining the Naive Human Pluripotent State 3.68
RNA-seq of RKO cells with cTAZ KO or putback 3.67
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 3.67
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 3.67
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 3.66
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 3.66
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 3.64
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 3.62
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 3.6
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 3.6
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 3.6
Biological effect of chronic mistranslation in mammalian cells 3.57
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 3.57
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 3.57
Noncoding regions are the main source of targetable tumor-specific antigens 3.57
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 3.53
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 3.51
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 3.49
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 3.49
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 3.44
Transcriptional profiling of LS1034 cells treated with tepoxalin 3.42
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 3.4
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 3.4
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 3.37
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 3.33
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 3.31
The Genetic Landscape of Diamond-Blackfan Anemia 3.29
Unique features and clinical importance of acute alloreactive immune responses 3.24
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 3.24
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 3.22
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 3.18
SLIGRL-induced gene expression changes in NHEK cells 3.16
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 3.11
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 3.07
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 3.06
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 3.06
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 3.06
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 3.0
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 2.98
The cohesin release factor WAPL restricts chromatin loop extension. 2.98
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 2.97
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 2.96
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 2.95
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 2.94
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 2.94
Systematic discovery of endogenous human ribonucleoprotein complexes 2.93
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 2.89
PRDM1 inhibits proliferation of human colon cancer organoids 2.85
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 2.84
Gene expression profiling in metabolically heterogeneous human lung tumors 2.84
SF3B1 Degron knockdown RNA-seq 2.83
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 2.81
Transcriptome of U251 cells overexpression complement component 7 2.81
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 2.78
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 2.78
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 2.73
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 2.73
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 2.73
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 2.72
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 2.69
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 2.68
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 2.62
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 2.6
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 2.58
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 2.55
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 2.55
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.55
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 2.5
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 2.5
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 2.49
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 2.49
Effect of PRDM11 depletion in U2932 cells 2.49
Ribosome profiling upon inhibition of eIF4A 2.48
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 2.43
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 2.42
CDK12 mediated transcriptional regulation in U2OS cells 2.41
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 2.4
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 2.39
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 2.38
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 2.29
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 2.28
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 2.28
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 2.23
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 2.21
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 2.2
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 2.2
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 2.18
Cell responses to dysregulated VZV-induced cell-cell fusion 2.17
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 2.16
RNA sequencing of matched nephrectomy samples [RNA-seq] 2.16
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 2.16
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 2.15
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 2.12
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 2.12
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 2.12
Real-time observation of light-controlled transcription in living cells 2.11
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 2.06
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 2.06
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 2.05
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 2.03
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 2.02
A20 regulates canonical wnt-signaling through an interaction with RIPK4 2.01
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 2.0
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 1.97
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 1.96
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 1.92
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 1.9
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 1.9
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 1.88
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 1.87
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 1.86
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 1.85
scRNASeq analysis of cycling cardiomyocytes 1.85
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 1.85
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 1.85
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 1.8
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 1.77
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 1.77
An siRNA screen identifies CHD4 as a target for epigenetic therapy 1.76
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 1.75
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 1.71
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 1.71
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 1.69
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 1.67
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.65
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 1.65
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.63
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 1.61
O-glcnAc reprograms cellular energetics 1.56
Functional significance of the HIV-1 Tat signature amino acid residues 1.54
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 1.52
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 1.51
The contribution of Alu exons to the human proteome 1.49
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 1.48
Transcriptional landscape changes during human embryonic stem cell derivation 1.47
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.45
circNFIB suppresses lymphatic metastasis of pancreatic cancer 1.43
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 1.43
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 1.39
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 1.38
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 1.38
Direct Isolation and Characterization of Human Nephron Progenitors. 1.37
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 1.35
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 1.34
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 1.31
Transcriptome of human ILC2s; primary vs IL-1b-primed 1.28
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.27
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 1.23
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 1.21
RNA-seq analysis of control and Myc-induced U2OS cells 1.2
Gene expression changes due to PARP knockdown in human cells 1.13
Role of COP1 on MAP kinase transcriptional output in melanoma 1.13
Human Treg IL-12 stimulation 1.12
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 1.12
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.11
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 1.09
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 1.09
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 1.08
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 1.02
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 0.98
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 0.95
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.93
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 0.92
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.89
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.88
Functional Haploid Human Oocytes Generated from Polar Body Genomes 0.88
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 0.88
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.88
Human Treg NaCl stimulation 0.86
Transcriptomic analysis of LSD1 0.86
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 0.85
RNA-seq of MDA-MB-231 cells with TET1 knockout 0.85
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 0.85
The bromodomain protein BRD4 regulates splicing during heat shock 0.82
Role of FGFR1 in neuronal devlopment 0.81
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 0.81
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 0.81
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 0.8
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 0.8
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 0.78
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 0.74
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.74
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.74
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 0.73
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.71
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 0.7
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.69
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 0.69
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 0.64
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 0.63
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 0.6
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 0.6
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 0.59
HBEC-shp53-PCHD7 0.57
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 0.57
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 0.56
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.56
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.56
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 0.56
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 0.56
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 0.5
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 0.5
Genome-wide analysis of the Integrator complex 0.44
Genome-wide analysis of the Integrator complex (HTS) 0.44
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.44
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 0.41
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.4
Impact on erythroid progenitor type on erythroid differntiation 0.39
SNHG5 siRNA knock down in HCT116 cells 0.39
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 0.38
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 0.38
p53 activity results in DNA replication fork processivity 0.36
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.35
RNA-seq data 0.32
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.29
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 0.29
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.29
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.28
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 0.23
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 0.23
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.21
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.21
Modulation of nonsense-mediated decay by rapamycin 0.2
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.19
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.19
siRNA-mediated knockdown 0.18
Myc activation coordinates gene transcription and protein translation responses 0.18
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.17
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.17
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.17
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.15
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.15
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.15
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.15
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 0.11
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 0.11
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 0.08
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.08
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.08
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.08
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.08
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.08
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.05
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.04
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.03


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation